Malaria drug fails to prevent COVID-19 in a rigorous study

A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis - The Lancet Infectious Diseases

Clinical trials planned to put hydroxychloroquine to the test for COVID-19

New Study Finds Hydroxychloroquine Did Not Prevent Covid-19 - The New York Times

Dr. Brechot's Health Research & Care Blog - October 28, 2022 - USF Health NewsUSF Health News

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies - Cytotherapy

The Strange and Twisted Tale of Hydroxychloroquine

Antimalaria Drug Doesn't Help Treat Covid-19, Large But Inconclusive Study Finds - WSJ

Can chloroquine prevent coronavirus disease?, News

Malaria drug touted by Trump fails to prevent COVID-19 in high profile study

US hospitals slash use of drug championed by Donald Trump as coronavirus treatment

Coronavirus: Malaria drug chloroquine unproven despite Trump comment

Malaria drug fails to prevent COVID-19 in a rigorous study

Malaria drug fails to prevent COVID-19 in a rigorous study (Update)